Mumbai, May 6 -- The inspection was conducted by Finnish Medicine Agency on behalf of EMA, from March 10 - 14, 2025 and concluded with few minor observations.
This GMP approval is for manufacturing, packaging, testing, storage and distribution of two types of complex dosage forms being produced from this facility -Oral Mouth Dissolving Films and Transdermal Systems. The Unit is already approved by MHRA, UK and TGA, Australia.
Oral Mouth Dissolving Films and Transdermal Systems are both, technology intensive, niche and complex dosage forms which offer significant advantages over conventional oral dosage forms in terms of patient convenience, dosing compliance and quick or sustained drug delivery for local and systemic therapy.
This Unit...